Antares Therapeutics Funding: $177M Raised, Series A (2025)
Antares Therapeutics is a Biotech company based in Boston. It has raised $177M in total funding. Latest round: Series A.
Antares Therapeutics funding overview
Antares Therapeutics is a Biotech company based in Boston. Antares Therapeutics has raised $177M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2025. The round record for Antares Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners, Cormorant Asset Management, Vinyanshu Ventures and 5 others. 11 distinct backers are named across the disclosed rounds.
Frequently asked about Antares Therapeutics funding
How much has Antares Therapeutics raised?
Antares Therapeutics has raised $177M in total disclosed funding across the rounds on record.
Who has invested in Antares Therapeutics?
Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners, Cormorant Asset Management, Vinyanshu Ventures are named among the investors backing Antares Therapeutics.
What was the latest Antares Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2025.
Where is Antares Therapeutics based?
Antares Therapeutics is based in Boston.
What sector does Antares Therapeutics operate in?
Antares Therapeutics is tracked under Biotech from Boston, with $177M in disclosed funding.
When did Antares Therapeutics last raise?
The last disclosed Antares Therapeutics round closed in June 2025 at Series A.
Totals shown for Antares Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
